Last reviewed · How we verify

NCT04581590

The Impact TDCS-linked Motor and Cognitive Training Gains in Parkinson's Disease

Active, enrolled NA Last updated 17 January 2025
What this trial tests

NA trial testing Cognitive training in Parkinson Disease in 242 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
3 October 2022
Primary endpoint
15 July 2024
2 February 2026

Quick facts

Lead sponsorFederal University of Paraíba
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposeprevention
Enrollment242
Start date3 October 2022
Primary completion15 July 2024
Estimated completion2 February 2026
Sites1 location across Brazil

Drugs / interventions tested

Conditions studied

Sponsor

Federal University of Paraíba

Who can join

Adults 40 to 70, any sex, with Parkinson Disease or Cognition Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is a group controlled clinical trial. Parallel study, patients aged 40-70 years, with Parkinson disease. Twelve sessions, three times a week, for 30 minutes, simultaneously to the rehabilitation program. Training will consist of Transcranial Direct Current Stimulation linked dual-task exercises or dual-taks exercises with cognitive training, applied three times a week during four weeks. The investigators will used instruments: dual-task gait speed (Auditory Stroop Task ), executive function (Wisconsin Card Sorting Test , Auditory Stroop Test, Trail Making Test, Verbal Fluency Test and Montreal Cognitive Assessment), and, the objective is to examine task-dependency in enhancing the effects of tDCS-linked rehabilitation training on PD and the relationships between baseline outcomes in responders and non-responders to therapy.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Can Task Specificity Impact tDCS-Linked to Dual Task Training Gains in Parkinson's Disease? A Protocol for a Randomized Controlled Trial.
    Costa-Ribeiro A, Andrade SMMDS, Férrer MLV, Silva OAPD, et al · · 2021 · cited 3× · PMID 34276344 · DOI 10.3389/fnagi.2021.684689

Verify or expand the search:

Other trials of Cognitive training

Trials testing the same drug.

Other recruiting trials for Parkinson Disease

Currently open trials in the same condition.

Other Federal University of Paraíba trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04581590.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing